CHUNLI MEDICAL (1858.HK)
- Previous Close
9.510 - Open
9.520 - Bid 10.180 x --
- Ask 10.220 x --
- Day's Range
9.520 - 10.360 - 52 Week Range
6.180 - 11.660 - Volume
2,379,000 - Avg. Volume
1,017,314 - Market Cap (intraday)
6.061B - Beta (5Y Monthly) -0.31
- PE Ratio (TTM)
28.50 - EPS (TTM)
0.360 - Earnings Date Apr 30, 2025 - May 6, 2025
- Forward Dividend & Yield 0.54 (5.69%)
- Ex-Dividend Date Jun 30, 2025
- 1y Target Est
11.63
Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or on ODM and OEM bases, as well as to hospitals directly. It also exports its products. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.
www.clzd.comRecent News: 1858.HK
View MorePerformance Overview: 1858.HK
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1858.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1858.HK
View MoreValuation Measures
Market Cap
5.62B
Enterprise Value
3.58B
Trailing P/E
26.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.13
Price/Book (mrq)
1.19
Enterprise Value/Revenue
4.10
Enterprise Value/EBITDA
19.51
Financial Highlights
Profitability and Income Statement
Profit Margin
15.71%
Return on Assets (ttm)
1.69%
Return on Equity (ttm)
4.39%
Revenue (ttm)
813.85M
Net Income Avi to Common (ttm)
127.86M
Diluted EPS (ttm)
0.360
Balance Sheet and Cash Flow
Total Cash (mrq)
1.8B
Total Debt/Equity (mrq)
0.03%
Levered Free Cash Flow (ttm)
-88.21M